This is a StreetInsider.com Premium Only Page

Alnylam Pharma (ALNY) – FDA

Mar 5, 2024 07:30 AM Alnylam Pharma (ALNY) Reports Positive KARDIA-2 Topline Study Results When Zilebesiran is Added to Standard of Care Antihypertensives

Nov 13, 2023 05:33 AM Alnylam Pharma (ALNY) Presents Positive Results from the KARDIA-1 Phase 2 Dose-Ranging Study of Zilebesiran

Oct 25, 2023 05:19 PM

Oct 25, 2023 11:13 AM

Oct 9, 2023 07:30 AM

Sep 13, 2023 04:57 PM

Sep 13, 2023 07:01 AM

Sep 11, 2023 09:24 AM

Sep 7, 2023 07:01 AM

Aug 28, 2023 09:13 AM

Jul 19, 2023 05:00 PM

Jul 17, 2023 05:54 AM

Jun 30, 2023 09:00 AM

May 22, 2023 05:46 AM

Apr 26, 2023 04:05 PM

Feb 21, 2023 08:01 AM

Dec 8, 2022 04:01 PM

Oct 7, 2022 06:12 AM

Sep 30, 2022 02:01 PM

Sep 20, 2022 07:02 AM

Sep 15, 2022 07:00 AM

Sep 8, 2022 06:26 AM

Aug 29, 2022 08:01 AM

Aug 3, 2022 07:01 AM

Jul 27, 2022 08:03 AM

Jul 22, 2022 08:17 AM

Jun 14, 2022 07:03 AM

Jun 9, 2022 07:00 AM

Jun 2, 2022 11:44 AM

May 24, 2022 07:02 AM

May 23, 2022 07:01 AM

Apr 4, 2022 07:34 AM

Mar 1, 2022 07:01 AM

Jan 21, 2022 07:30 AM

Jan 14, 2022 07:03 AM

Jan 6, 2022 07:36 AM

Dec 30, 2021 10:05 AM

Dec 28, 2021 06:02 AM

Dec 27, 2021 09:21 AM

Dec 27, 2021 07:52 AM

Dec 22, 2021 04:23 PM

Dec 22, 2021 07:02 AM

Dec 20, 2021 07:03 AM

Dec 14, 2021 07:05 AM

Nov 15, 2021 05:26 AM

Nov 5, 2021 01:30 PM

Oct 28, 2021 08:41 AM

Oct 27, 2021 04:00 PM

Sep 13, 2021 07:01 AM

Sep 7, 2021 07:07 AM